| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « May | Jul » | |||||
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | |
June 7th, 2012 tmccoy
by: William Dubanevich, Esq. A panel of seven Commonwealth Court judges must decide whether the State of Pennsylvania was overreaching its bounds by creating a law that outlined where drilling sites and compressor stations can be located. Lawyers representing the municipalities are arguing that state limitations on how municipalities can craft zoning rules are inappropriate. [...]
June 7th, 2012 tmccoy
by: Stephanie Herschaft, Esq. In 2011, the Food and Drug Administration received 179,855 reports of serious or fatal adverse drug reactions. 158,853 reports were from manufacturers and 21,002 were voluntary reports. Drug manufacturers are required to report serious events that come to their attention within fifteen days. The number of serious or fatal adverse reactions [...]
June 7th, 2012 tmccoy
by: Jonathan Macri, Esq. Parents of infants and small children should be very careful the next time they administer acetaminophen to their young ones, as a recent report warns that acute acetaminophen overdose is the most common identifiable cause of acute liver failure in children. The report, released by the Canadian Medical Association Journal, states [...]
June 7th, 2012 tmccoy
by: Michael Werner, Esq. Patient-safety groups are publicly alleging that Ciba Vision has failed to adequately warn consumers of potential injuries that may be caused by Clear Care contact lens solution. Clear Care contains approximately 3% hydrogen peroxide—a chemical uncommon to traditional contact lens solutions. To date, Ciba Vision’s way of confronting this potentially harmful [...]
June 7th, 2012 tmccoy
by: Jonathan Macri, Esq. The noise surrounding the workout stimulant known as DMAA continues to grow louder as regulators continue to receive pressure about taking action against a substance that is being viewed as increasingly more dangerous by the day. DMAA, a stimulant currently found in over 200 products sold under various names, including Hemo [...]
June 7th, 2012 tmccoy
by: Michael Werner, Esq. Anticoagulant drug Pradaxa has received a rather inauspicious acknowledgment by the U.S. Food and Drug Administration (“FDA”). Accordingly to the FDA MedWatch reporting system, last year Pradaxa lead all other drugs in several categories, including overall number of adverse reports (3,781); death (542); hemorrhage (2,367); acute rental failure (291); and stroke [...]
